These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 15030392)
1. Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3. Berent-Spillson A; Robinson AM; Golovoy D; Slusher B; Rojas C; Russell JW J Neurochem; 2004 Apr; 89(1):90-9. PubMed ID: 15030392 [TBL] [Abstract][Full Text] [Related]
6. Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain - relation to brain concentration. Nagel J; Belozertseva I; Greco S; Kashkin V; Malyshkin A; Jirgensons A; Shekunova E; Eilbacher B; Bespalov A; Danysz W Neuropharmacology; 2006 Dec; 51(7-8):1163-71. PubMed ID: 16926034 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism. Xi ZX; Li X; Peng XQ; Li J; Chun L; Gardner EL; Thomas AG; Slusher BS; Ashby CR J Neurochem; 2010 Jan; 112(2):564-76. PubMed ID: 19895667 [TBL] [Abstract][Full Text] [Related]
8. Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG). Hicks C; Gregg RA; Nayak SU; Cannella LA; Schena GJ; Tallarida CS; Reitz AB; Smith GR; Rawls SM Psychopharmacology (Berl); 2017 Jun; 234(11):1671-1681. PubMed ID: 28251297 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of glutamate carboxypeptidase II (NAALADase) protects against dynorphin A-induced ischemic spinal cord injury in rats. Long JB; Yourick DL; Slusher BS; Robinson MB; Meyerhoff JL Eur J Pharmacol; 2005 Jan; 508(1-3):115-22. PubMed ID: 15680261 [TBL] [Abstract][Full Text] [Related]
10. N-acetyl-aspartyl-glutamate and inhibition of glutamate carboxypeptidases protects against soman-induced neuropathology. Guo H; Liu J; Van Shura K; Chen H; Flora MN; Myers TM; McDonough JH; McCabe JT Neurotoxicology; 2015 May; 48():180-91. PubMed ID: 25825357 [TBL] [Abstract][Full Text] [Related]
11. Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats. Yamamoto T; Saito O; Aoe T; Bartolozzi A; Sarva J; Zhou J; Kozikowski A; Wroblewska B; Bzdega T; Neale JH Eur J Neurosci; 2007 Jan; 25(1):147-58. PubMed ID: 17241276 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia. Cai Z; Lin S; Rhodes PG Eur J Pharmacol; 2002 Feb; 437(3):139-45. PubMed ID: 11890901 [TBL] [Abstract][Full Text] [Related]
13. Effects of GCP-II inhibition on responses of dorsal horn neurones after inflammation and neuropathy: an electrophysiological study in the rat. Carpenter KJ; Sen S; Matthews EA; Flatters SL; Wozniak KM; Slusher BS; Dickenson AH Neuropeptides; 2003 Oct; 37(5):298-306. PubMed ID: 14607107 [TBL] [Abstract][Full Text] [Related]
15. NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia. Olszewski RT; Janczura KJ; Ball SR; Madore JC; Lavin KM; Lee JC; Lee MJ; Der EK; Hark TJ; Farago PR; Profaci CP; Bzdega T; Neale JH Transl Psychiatry; 2012 Jul; 2(7):e145. PubMed ID: 22850437 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta. Thomas AG; Liu W; Olkowski JL; Tang Z; Lin Q; Lu XC; Slusher BS Eur J Pharmacol; 2001 Oct; 430(1):33-40. PubMed ID: 11698060 [TBL] [Abstract][Full Text] [Related]
17. Regulation of glutamate carboxypeptidase II hydrolysis of N-acetylaspartylglutamate (NAAG) in crayfish nervous tissue is mediated by glial glutamate and acetylcholine receptors. Urazaev AK; Grossfeld RM; Lieberman EM J Neurochem; 2005 May; 93(3):605-10. PubMed ID: 15836619 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons. Tortella FC; Lin Y; Ved H; Slusher BS; Dave JR Eur J Pharmacol; 2000 Aug; 402(1-2):31-7. PubMed ID: 10940354 [TBL] [Abstract][Full Text] [Related]